期刊文献+

非酒精性脂肪性肝病的心血管疾病相关风险研究进展

Research Progress in Risk of Cardiovascular Disease in Non-alcoholic Fatty Liver Disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是一种可影响全身多个脏器与系统的多因素疾病,与心血管疾病(CVD)的发生有密切联系。NAFLD可增加冠心病、瓣膜性心脏病、心功能不全、心律失常等CVD事件的发生风险,且独立于传统的心脏代谢危险因素。NAFLD与CVD之间关联的可能机制包括遗传易感性、胰岛素抵抗、血栓形成风险增加、动脉粥样硬化性血脂异常、氧化应激和全身炎症反应等。提高临床医师对NAFLD的认识,早期识别NAFLD患者并加强管理,对CVD的发生有较好的预防作用。 Non-alcoholic fatty liver disease(NAFLD)is a multifactorial disease that can affect a variety of organs and systems of the whole body,and has a close relationship with the occurrence of cardiovascular disease(CVD).NAFLD can increase the risk of coronary heart disease,valvular heart disease,cardiac dysfunction,arrhythmia and other CVD events,independent of traditional cardiometabolic risk factors.Possible mechanisms for the association between NAFLD and CVD include genetic susceptibility,insulin resistance,high risk of thrombosis,atherosclerotic dyslipidemia,oxidative stress and systemic inflammatory responses.Raising the the clinicians′awareness of NAFLD and realizing early identification and management of NAFLD patients have a good preventive effect on the occurrence of CVD.
作者 石晓兰 刘晓琳 邹嘉缪 严苏 SHI Xiaolan;LIU Xiaolin;ZOU Jiamiu;YAN Su(Department of Gastroenterology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China)
出处 《医学综述》 CAS 2022年第21期4250-4256,共7页 Medical Recapitulate
关键词 非酒精性脂肪性肝病 代谢综合征 冠心病 心律失常 胰岛素抵抗 Non-alcoholic fatty liver disease Metabolic syndrome Coronary atherosclerotic heart disease Arrhythmia Insulin resistance
  • 相关文献

参考文献5

二级参考文献33

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1515
  • 2Masahide Hamaguchi,Takao Kojima,Noriyuki Takeda,Chisato Nagata,Jun Takeda,Hiroshi Sarui,Yutaka Kawahito,Naohisa Yoshida,Atsushi Suetsugu,Takahiro Kato,Junichi Okuda,Kazunori Ida,Toshikazu Yoshikawa.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease[J].World Journal of Gastroenterology,2007,13(10):1579-1584. 被引量:56
  • 3朱红霞 朱筠 张明琛 等.维吾尔族和汉族2型糖尿病合并非酒精性脂肪肝患者的代谢特征及相关危险因素探讨.中国全科医学,2009,12(7):1164-1164.
  • 4范建高,曾民德.脂肪性肝病[M].北京:人民卫生出版社,2013:137-147.
  • 5Executive summary of the third report of the national cholesterol education program (NCEP). Expert panel on detection,evaluation,and treatment of high blood choles terol in adults(adult treatment panel Ⅲ)[J]. JAMA, 2001,285(19) :2486-2497.
  • 6Gensini GG. A more meaningful scoring system for deter- mining the severity of coronary heart disease[J]. Am J Cardiol,1983 , 51(3):606-607.
  • 7Matteoni CA, Younossi ZM, Gramlieh T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and patho logical severity[-J]. Gastroenterology, 1999,116(6) : 1413- 1419.
  • 8Yesilova Z,Yaman H,Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease[J]. Am J Gastroenterol, 2005,100(4) :850-855.
  • 9Brea A, Mosquera D, Martin E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis. A case control study[J]. Arterioscler Thromb Vasc Biol, 2005,25(5) : 1045-1050.
  • 10Ali R,Cusi K. New diagnostic and treatment spproaehes in non-alcoholic fatty liver disease (NAFLD)[J]. Ann Med,2009,41(4):265-278.

共引文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部